No Data
Examining the Future: Co-Diagnostics's Earnings Outlook
Trump wants to impose tariffs on Pharmaceuticals: Pharmaceutical companies are busy stockpiling, and the import volume in the USA surged in March.
① The volume of Pharmaceutical imports in the USA surged in March, as pharmaceutical companies stockpiled products in anticipation of potential tariffs; ② A report released by the US Department of Commerce on Tuesday showed that the total value of Pharmaceutical imports in March exceeded 50 billion USD, equivalent to 20% of the total Pharmaceutical imports for the entire year of 2024.
Earnings Preview: CODX to Report Financial Results Post-market on May 08
Co-Diagnostics, Inc. Announces First Quarter 2025 Earnings Release Date and Webcast
This Kohl's Analyst Begins Coverage On A Bearish Note; Here Are Top 5 Initiations For Monday
Express News | D. Boral Capital Initiates Coverage On Co-Diagnostics With Buy Rating, Announces Price Target of $10